# Olfactory Cleft Obstruction and Electrophysiological Field Potentials Predict Olfactory Restoration by Dupilumab in CRSwNP Patients.

> **NCT06892704** · — · RECRUITING · sponsor: **Northwestern University** · enrollment: 30 (estimated)

## Conditions studied

- Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)
- Smell Loss

## Interventions

- **DRUG:** Dupilumab - Standard Dose

## Key facts

- **NCT ID:** NCT06892704
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2027-04-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06892704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06892704, "Olfactory Cleft Obstruction and Electrophysiological Field Potentials Predict Olfactory Restoration by Dupilumab in CRSwNP Patients.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06892704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*